These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
303 related items for PubMed ID: 25524480
1. Functional outcome of supratrigonal cystectomy and augmentation ileocystoplasty in adult patients with refractory neurogenic lower urinary tract dysfunction. Krebs J, Bartel P, Pannek J. Neurourol Urodyn; 2016 Feb; 35(2):260-6. PubMed ID: 25524480 [Abstract] [Full Text] [Related]
2. Supratrigonal cystectomy with Hautmann pouch as treatment for neurogenic bladder in spinal cord injury patients: long-term functional results. Gobeaux N, Yates DR, Denys P, Even-Schneider A, Richard F, Chartier-Kastler E. Neurourol Urodyn; 2012 Jun; 31(5):672-6. PubMed ID: 22532256 [Abstract] [Full Text] [Related]
3. Efficacy and safety of augmentation ileocystoplasty combined with supratrigonal cystectomy for the treatment of refractory bladder pain syndrome/interstitial cystitis with Hunner's lesion. Kim HJ, Lee JS, Cho WJ, Lee HS, Lee HN, You HW, Jung W, Lee KS. Int J Urol; 2014 Apr; 21 Suppl 1():69-73. PubMed ID: 24807503 [Abstract] [Full Text] [Related]
4. Urinary continence outcome after augmentation ileocystoplasty as a single surgical procedure in patients with myelodysplasia. Medel R, Ruarte AC, Herrera M, Castera R, Podesta ML. J Urol; 2002 Oct; 168(4 Pt 2):1849-52. PubMed ID: 12352374 [Abstract] [Full Text] [Related]
5. Long-term clinical and urodynamic effectiveness of augmentation ileocystoplasty with supra-trigonal cystectomy in individuals with spinal cord injury. Balanca A, Even A, Malot C, Chartier-Kastler E, Denys P, Joussain C. World J Urol; 2022 Aug; 40(8):2121-2127. PubMed ID: 35680652 [Abstract] [Full Text] [Related]
6. Differences in urodynamic study variables in adult patients with neurogenic bladder and myelomeningocele before and after augmentation enterocystoplasty. Vainrib M, Reyblat P, Ginsberg DA. Neurourol Urodyn; 2013 Mar; 32(3):250-3. PubMed ID: 22965686 [Abstract] [Full Text] [Related]
10. Neurogenic lower urinary tract dysfunction: how, when, and with which patients do we use urodynamics? Danforth TL, Ginsberg DA. Urol Clin North Am; 2014 Aug; 41(3):445-52, ix. PubMed ID: 25063601 [Abstract] [Full Text] [Related]
14. Long-term outcomes of augmentation ileocystoplasty in patients with spinal cord injury: a minimum of 10 years of follow-up. Gurung PM, Attar KH, Abdul-Rahman A, Morris T, Hamid R, Shah PJ. BJU Int; 2012 Apr; 109(8):1236-42. PubMed ID: 21851549 [Abstract] [Full Text] [Related]
15. Long term results of augmentation cystoplasty and urinary diversion in multiple sclerosis. Kalkan S, Jaffe WI, Simma-Chiang V, Li ESW, Blaivas JG. Can J Urol; 2019 Jun; 26(3):9774-9780. PubMed ID: 31180308 [Abstract] [Full Text] [Related]
18. Augmentation cystoplasty: Urodynamic and metabolic outcomes at 10-year follow-up. Cheng KC, Kan CF, Chu PS, Man CW, Wong BT, Ho LY, Au WH. Int J Urol; 2015 Dec; 22(12):1149-54. PubMed ID: 26391472 [Abstract] [Full Text] [Related]
19. Detrusor Acontractility after Acute Spinal Cord Injury-Myth or Reality? Bywater M, Tornic J, Mehnert U, Kessler TM. J Urol; 2018 Jun; 199(6):1565-1570. PubMed ID: 29352989 [Abstract] [Full Text] [Related]
20. Long-term beneficial effects of mirabegron in pediatric patients with therapy-refractory neurogenic lower urinary tract dysfunction. van Veen FEE, Schotman M, 't Hoen LA, Blok BFM, Scheepe JR. J Pediatr Urol; 2023 Dec; 19(6):753.e1-753.e8. PubMed ID: 37658014 [Abstract] [Full Text] [Related] Page: [Next] [New Search]